Kevin Lee Freeman - Jun 11, 2024 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Commercial Officer
Signature
/s/Benjamin Landry, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Jun 11, 2024
Transactions value $
-$49,008
Form type
4
Date filed
6/12/2024, 04:25 PM
Previous filing
Jun 4, 2024
Next filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Sale -$49K -7.5K -2.74% $6.53 266K Jun 11, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 11th, 2024 in accordance with Rule 10b5-1.